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ABSTRACT
Background:
 Though laparoscopic distal gastrectomy has become a standard procedure for treatment 
of gastric cancer, laparoscopic total gastrectomy has not been widely accepted as it 
requires more dexterity and lack of evidence about its feasibility and safety. 
Methods:
Here retrospectively we review a series of 12 cases of gastric cancer undergone 
laparoscopic total gastrectomy with D1 or D2 lymphadenectomy over a period of 10 
years at a tertiary care hospital. The patient demographic characteristics were reviewed 
and the outcomes after surgery was analyzed in terms of extent of lymphadenectomy, 
mean operative time, mean intraoperative blood loss median number of lymph nodes 
harvested, median time for postoperative ambulation, median time for postoperative 
oral feeding, median time of postoperative hospital stay, postoperative complications 
and mortality.          
Results:
All patients had total gastrectomy entirely through laparoscopic method. Mean 
operative time was 282 minutes, mean intraoperative blood loss was 120 ml, median 
time for ambulation and oral feeding was 3 days and 6 days respectively. Median time 
of hospital stay was 16 days and 2 patients had complications as pancreatic fistula and 
port site abscess. No mortality was observed.
Conclusion: 
With zero mortality and accepted rate of complications, laparoscopic total gastrectomy 
appears to be technically feasible and safe for management of gastric cancer. But more 
studies have to be conducted with comparison to other standard gastrectomies and long 
term follow up to be done to establish its standardized application
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Background:
Gastric cancer is still a dreaded malignancy, being the 
fourth most common cancer and the third leading cause 
of cancer-related death worldwide [1]. Controversy 
persists regarding the laparoscopic approach for various 
gastric oncological procedures, although support and 
evidence for the minimally invasive approach is growing 
[2,3]. In 1994, Kitano performed the first laparoscopic 
assisted distal gastrectomy with a modified D1 lymph 
node dissection for the treatment esophago-gastric cancer 
with high risk of lymph node metastasis. Laparoscopy-
assisted distal gastrectomy has become the recognized 
procedure for early gastric cancer [4-6]. Its benefits 
over conventional open gastrectomy, such as improved 
cosmetics and reduced postoperative pain, have been 
well documented. But unlike this, laparoscopic total 
gastrectomy remains a challenging procedure and the 
technique has not yet been standardized [7]. This is partly 
related to skepticism regarding oncologic results for this 
advanced surgical procedure with a significant learning 
curve.  Laparoscopic gastrectomy is a well-established 
technique for treating gastric cancer in Eastern 
countries. According to national surveys, LG accounted 
for approximately 25% of all gastric surgeries performed 
for cancer in Japan and South Korea as early as 2009 
[8]. In 1996, Azagra et al reported the first laparoscopic 
total gastrectomy for cancer There are few studies on 
the outcomes of laparoscopic total gastrectomy with D1 
or D2 lymphadenectomy for gastric cancer because of 
technical difficulty in completing the procedures and 
concerns about long-term oncologic outcomes. The 
application of laparoscopic total gastrectomy with D2 
lymphadenectomy for gastric cancer raises 2 problems: 
whether and how to perform a concomitant splenectomy 
to completely retrieve station 10 lymph nodes and how 
to accomplish an intracorporeal anastomosis. The former 
is also a matter of debate for open surgery, and the latter 
is the key to success for a totally laparoscopic approach.
Herein we report our experience with the feasibility, 
safety and postoperative outcomes of 12 cases of gastric 
cancer undergone laparoscopic total gastrectomy with 
lymphadenectomy by a single surgeon and his team. 
Methods:
Total 12 patients of gastric cancer had undergone 
laparoscopic total gastrectomy with D1 and D2 
lymphadenectomy at S.C.B. Medical College and 
Hospital, Cuttack & AIIMS Bhubaneswar, Odisha from 
March 2010 to July 2019. Retrospectively the details of 
their treatment and hospital stay was retrieved from 
the computerized patient database. The data was 
collected regarding age, sex, height, weight, body mass 
index (BMI), clinical and pathological stage, extent of 
gastrectomy and lymph node dissection, operative 
time, intraoperative blood loss, postoperative hospital 
stay, oral intake rate, intraoperative and postoperative 
complications, mortality and re-admission rate. The 
patient and surgical characteristics are given in Table 1. 
All patients were found to be histologically diagnosed 
as adenocarcinoma of stomach of various stages and had 
undergone laparoscopic total gastrectomy and Roux-
en-Y reconstruction with a stapled esophagojejunostomy.
Median age (years) 58.6 ±8.2 (42-69)
Sex
Male 11
Female 1
Mean BMI (Body Mass Index)         19.2 (17.4-31.7)
American society of Anaesthesiologists class
ASA 1 0
ASA 2 8
ASA 3 4
Location of gastric cancer
Whole  4
Upper 6
Middle 2
Table 1: Patient characteristics. 
Operative intervention was done as D1 to D1+ resection 
for early gastric cancer and D2 resection was performed 
for advanced gastric cancer (Figure 1) according to the 
criteria of gastric cancer treatment guidelines of JGCA 
[9]. The standard operative procedure followed was as 
below.
Figure 1: Lymphadenectomy.
After the establishment of a pneumoperitoneum at 10 to 
12 mm Hg, a laparoscope was introduced through the 
infraumbilical port. The other 4 trocars, inserted under 
laparoscopic guidance, consisted of two 5-mm bilateral 
subcostal ports and two 12-mm bilateral low abdominal 
ports. At the beginning of each operation, the peritoneal 
cavity was carefully inspected and cytologic examination 
by peritoneal lavage was performed to detect 
macroscopic or microscopic peritoneal dissemination of 
tumor cells.
An avascular area of the gastrocolic ligament was 
divided toward the lower pole of the spleen by means 
of laparosonic coagulation shears and all lymph nodes 
along the gastroepiploic vessels (stations 4d and 4sb) 
were dissected, and then the division was extended 
distally toward the pylorus by means of laparosonic 
coagulation shears. The right gastroepiploic vessels were 
exposed and divided with a single clip at their origins, 
thus allowing dissection of the infrapyloric lymph nodes 
(station 6) from the pancreatic head.
The peritoneum along the inferior pancreatic margin 
was incised with an electrocautery. The body of the 
gland was lifted from its bed and further mobilized as 
far as necessary, and the splenic vein and artery were 
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isolated. The caudal gland of the pancreas was retracted 
gently downward by gauze traction so that the upper 
border of the pancreas was moved forward. The splenic 
artery was immediately identified through the lesser sac 
and was divided between clips distal to the origin of the 
dorsal pancreatic artery.
The lower esophagus was adequately mobilized (Figure 
2, Figure 3) and transected (Figure 4) by means of a 45-
mm endoscopic stapling device. 
The stumps of the excised portion of the esophagus 
were submitted for frozen-section examination with 
hematoxylin-eosin staining during the operation in 
patients with intraoperative suspected tumor invasion of 
the esophagus. The whole stomach and the body and tail 
of the pancreas, together with the spleen, were turned 
over to the right, exposing their posterior surfaces. The 
fatty connective tissue including lymph nodes around 
the splenic artery (stations 11p and 11d) was completely 
removed and the caudal splenic artery was divided with 
clips. The splenic vein was preserved on the whole length 
of the pancreas and divided between clips just distal to 
the point of entry to the pancreas tail. The celiac and 
left gastric arteries were approached from the left and 
behind. The root of the left gastric artery was divided 
with double clips (Figure 5), followed by dissection of 
lymph nodes along the celiac artery (station 9) and the 
left gastric artery (station 7). 
The whole of the stomach was turned down and the 
duodenum was transected at 1 cm distal to the pylorus 
with the endoscopic stapling device (Figure 6). 
The hepatoduodenal ligament was dissected, and then 
the right gastric artery was exposed and divided at its 
origin, allowing dissection of the suprapyloric lymph 
nodes (station 5). The lymph nodes along the common 
hepatic (station 8a) and proper hepatic (station 12a) 
arteries were removed en bloc just anterior to the portal 
vein. Finally, the resected organs and lymph nodes 
were placed in a plastic bag and extracted through the 
umbilical incision extended vertically for 40 mm. A 
proximal margin of at least 2 cm is recommended for T1 
tumors, 3 cm is recommended for T2 or deeper tumors 
with an expansive growth pattern (Bormann I and II), 
and 5 cm is recommended for those with infiltrative 
growth pattern (Bormann III and IV).
After total gastrectomy, intracorporeal anastomosis 
was accomplished by the Roux-en-Y method with a 
functional side-to-side anastomotic technique. The 
ligament of Treitz was identified and the jejunum was 
divided at 20 cm distally. The distal limb of the jejunum 
was brought up in an antecolic fashion. An enterotomy 
was made by electrocautery in the antimesenteric side of 
the jejunum and the posterior side of the esophagus to 
allow passage of the 2 forks of the endoscopic stapling 
device. The stapling device was closed and fired to create 
the anastomosis (Figure 7). The connected stab incision 
was closed with 2 or 3 applications of the stapler (Figure 
8). The side-to-side enteroenterostomy to the Roux limb 
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Figure 2: Hiatal dissection. 
Figure 5: Managing left gastric vessels.  
Figure 3: Mobilised oesophagus.  
Figure 4: Oesophageal transection.
Figure 6: Duodenal division.
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was made at 50 cm below the esophagojejunostomy by 
means of the same stapling technique (Figure 9). 
Two soft tube drains were usually placed, one in 
the left subphrenic space and another near the 
esophagojejunostomy through separate bilateral ports, 
and left for 3 or 4 days. 
After discharge from our hospital all the patients had 
undergone oncological evaluation at regional cancer 
center to receive postoperative adjuvant chemotherapy 
and/or radiotherapy.
Results
There were 11 males (91.7%) and 1 female (8.3%) with 
a median age of 58.6 years (range 42-69 years). All of 
them had comorbidities with 8 patients (75%) under 
ASA class II and 4 patients (25%) under ASA class III. 
No patient had history of any previous laparoscopic 
surgery or laparotomy. The surgical characteristics were 
as given in Table 2. In clinicopathological staging, 3 
patients were under stage IA, 4 under stage IB, 2 under 
stage IIA, 1 under stage IIB and 2 patients under stage III 
(according to the International Union Against Cancer- 
TNM staging). 
All the procedures were accomplished entirely through 
laparoscopic approach. The mean operative time 
was 282 minutes (range 230-465 minutes). The mean 
intraoperative blood loss was 120 ml (range 50-650 ml) 
and blood transfusion was needed for 2 patients during 
surgery, with 1 unit for each. D1 lymphadenectomy was 
done in 3 patients, D1+ lymphadenectomy in 5 patients, 
D2 lymphadenectomy was done in 4 patients and 1 
patient had undergone concurrent splenectomy. The 
median number of lymph nodes harvested was 26 (range 
18-42) and positive lymph node metastasis was found 
in 9 patients. The median time period of postoperative 
ambulation was 3 days (range 2-5 days) and 6 days 
(range 5-8 days) for postoperative oral feeding. The 
median duration of postoperative hospital stay was 16 
days (range 13- 83 days). 10 patients had uneventful 
postoperative hospital stay, 2 patients had complications 
leading to longer hospital stay. Out of 12 patients, 2 had 
developed complications. The patient with concurrent 
splenectomy developed pancreatic fistula which was 
managed conservatively with keeping the drain for 
longer time which was placed during laparoscopic total 
gastrectomy and CT guided percutaneous drainage 
later. Another patient developed port site abdominal 
wall abscess which was managed conservatively 
and local abscess site exploration. No patient had 
undergone abdominal re-explorative surgery. No other 
postoperative complication was observed. There was 
no mortality during in-hospital stay and 30 days after 
discharge till 2nd follow up visit of the patients. Table 2.
Stage
IA 3 patients
IB 4 patients
II 2 patients
IIB 1 patient
III 2 patients
IV 0 patients
Extent of lymphadenectomy
D1 3 patients
D1+ 5 patients
D2 4 patients
Mean operative time (minutes)                                        282 ± 37.5 (230-
465)
Mean intraoperative blood loss (ml)                                 120 ml (50- 650)
Median number of lymph nodes harvested                     26 (18-42)
 Positive lymph node metastasis                                               9 patients
Median time for postoperative ambulation             3 days (2-5 days)
Median time for postoperative oral feeding             6 days (5-8 days)  
Median time of postoperative hospital stay 16 days (13-83 
days)
Postoperative complication                
 Pancreatic fistula                                                                    1 patient
Port site abscess                                                    1 patient
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Figure 7: Oesophagojejunostomy.
Figure 8: Oesophagojejunostomy stoma closure. 
Figure 9: Enteroenterostomy.
Table 2: Surgical Characteristics.
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Discussion:
Recently, several studies on laparoscopic total 
gastrectomy for gastric cancer have shown not only 
favorable short-term outcomes but also acceptable long-
term oncologic safety [10,11]. In contrast to laparoscopic 
partial gastric resections for early gastric cancer, 
studies on laparoscopic total gastrectomy for gastric 
cancer are lacking [12,13]. In this case series report 
we have successfully performed 12 laparoscopic total 
gastrectomies with a complete D1 or D2 lymph node 
dissection without conversion to open laparotomy. To 
the best of our knowledge, this is the first report on the 
outcomes of laparoscopic total gastrectomy on a series of 
gastric cancer patients in the state.
In the present series, the hospital mortality rate was 
zero and the overall complication rate was 16.7% with 1 
patient had pancreatic fistula, which less than the rates of 
33% reported for aa large series of patients undergoing 
laparoscopic open D2 total gastrectomy with splenectomy 
[14]. Like open resection, D2 total gastrectomy with 
splenectomy for gastric cancer is still debated [14-20]. In 
few European randomized control trials, splenectomy 
was strongly associated with increased mortality and 
morbidity after D2 total gastrectomy [21,22]. Hence, 
authors in Western countries have recommended that 
splenectomy be abandoned unless the tumor directly 
invades the spleen or involves the splenic hilar nodes. 
In Japan, on the contrary, splenectomy has not been 
considered an independent determinant of morbidity 
and mortality associated with D2 total gastrectomy [23].
Lymph node metastasis of gastric cancer is frequently 
encountered around the suprapancreatic area such 
as at stations 7, 8, 9, and 11 [24]. Moreover, complete 
dissection of this area is an important element of curative 
surgical treatment for gastric cancer [20]. Our technique 
consists of dissection of the suprapancreatic lymph 
nodes with initial mobilization of the pancreatic body 
and downward retraction of the caudal gland of the 
pancreas by gauze traction to look for the upper border 
of the pancreas. These steps have helped us to perform 
meticulous dissection of lymph nodes without injuring 
the pancreatic parenchyma by using an ultrasonic device 
or clips if needed. Consequently, the number of lymph 
nodes removed in our series exceeded 20, indicating that 
laparoscopic treatment has not compromised adequate 
lymph node sampling. One of the major concerns in 
conducting laparoscopic total gastrectomy with D2 
lymphadenectomy was the prolonged operation time, 
which may increase morbidity. However, in our series, 
the hospital mortality rate was zero and there was 
acceptable morbidity.
Although laparoscopic surgery has a clear benefit 
regarding postoperative hospital stay, in our series the 
hospital stay was relatively long: a median of 16 days 
overall and maximum 83 days. However, our patients 
experienced a good postoperative recovery, with a 
median time to postoperative ambulation of 3 days and 
a median time to oral feeding of 6 days. This is consistent 
with the faster recovery noted for laparoscopy-assisted 
distal gastrectomy for early gastric cancer [4-6]. 
Therefore, it is possible that postoperative hospital stay 
will be shorter in the near future.
The most widespread technique for esophagojejunostomy 
is an anastomosis with a circular stapler prepared for 
open operation. However, for laparoscopic operation, 
this technique is complicated with technical difficulty, 
and a minilaparotomy or an extended auxiliary incision 
on the abdominal wall for insertion of the circular 
device may spoil the merit of the totally laparoscopic 
operation [25]. Our technique for intracorporeal 
esophagojejunostomy was derived from the application 
of the functional side-to-side technique to the anastomosis 
between the antimesenteric side of the distal limb of the 
jejunum and the posterior side of the esophagus [26]. 
By means of the described technique, intracorporeal 
esophagojejunostomy can be performed with the use of 
a 45-mm linear stapler through a 12-mm low abdominal 
port without forceful extraction of the surgical specimen. 
We found that intracorporeal esophagojejunostomy 
using an endoscopic linear stapler is a simple technique 
that does not reduce the advantages of laparoscopic 
gastric resection.
Conclusion:
The mortality rate of zero and acceptable morbidity of our 
series shows that laparoscopic total gastrectomy with D1 
or D2 lymphadenectomy for gastric cancer is technically 
feasible and is safe in the hands of experienced surgeons. 
Although comparative studies with larger sample size, 
suitable control groups and long term follow up is 
necessary to confirm this, it yields adequate number of 
lymph nodes for accurate pathological staging against 
the anticipation. The findings of our retrospective case 
series are hoped for contributing to the evidence-based 
information about the safety, feasibility and outcomes of 
laparoscopic total gastrectomy for gastric cancer though 
many future studies are necessary to validate the long-
term oncologic outcomes.
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